Oral administration of Simbioflora® (synbiotic) attenuates intestinal damage in a mouse model of 5-fluorouracil-induced mucositis

Beneficial Microbes

Volumn 9, Issue 3, 2018, Pages 477-486

  Trindade, L M ^a   Martins, V D ^a   Rodrigues, N M ^a   Souza, E L S ^a   Martins, F S ^a   Costa, G M F ^a   Almeida Leite, C M ^a   Faria, A M C ^a   Cardoso, V N ^a   Maioli, T U ^a   Generoso, S V ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Mucositis; Prebiotic; Short chain fatty acid; Synbiotic

Indexed keywords

EOSINOPHIL PEROXIDASE; FLUOROURACIL; FRUCTOSE OLIGOSACCHARIDE; SHORT CHAIN FATTY ACID; SIMBIOFLORA; SYNBIOTIC AGENT; OLIGOSACCHARIDE; VOLATILE FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM ANIMALIS; BODY WEIGHT LOSS; CELL INFILTRATION; DRUG EFFICACY; DRUG RESPONSE; ENZYME ACTIVITY; EOSINOPHIL; HISTOLOGY; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS RHAMNOSUS; MALE; MUCOSA INFLAMMATION; NEUTROPHIL; NONHUMAN; ANIMAL; BAGG ALBINO MOUSE; BODY WEIGHT; CHEMICALLY INDUCED; CHEMISTRY; FECES; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; LACTOBACILLUS; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; BIFIDOBACTERIUM ANIMALIS; BODY WEIGHT; FATTY ACIDS, VOLATILE; FECES; FLUOROURACIL; GASTROINTESTINAL TRACT; LACTOBACILLUS; MICE, INBRED BALB C; MUCOSITIS; OLIGOSACCHARIDES; SYNBIOTICS; TREATMENT OUTCOME;

EID: 85046723092     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2017.0082     Document Type: Article

References (42)

1. Ahl, D., Liu, H., Schreiber, O., Roos, S., Phillipson, M. and Holm, L., 2016. Lactobacillus reuteri increases mucus thickness and ameliorates dextran sulphate sodium-induced colitis in mice. Acta Physiology 217: 300-310.
2. Ahmad, A.S., Ormiston-Smith, N. and Sasieni, P.D., 2015. Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960. British Journal of Cancer 112: 943-947.
3. Alexander, J.L., Wilson, I.D., Teare, J., Marchesi, J.R., Nicholson, J.K. and Kinross, J.M., 2017. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nature Reviews Gastroenterology and Hepatology 14: 356-365.
4. Arantes, R.M., Marche, H.H., Bahia, M.T., Cunha, F.Q., Rossi, M.A. and Silva, J.S., 2004. Interferon-gamma-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice. American Journal of Pathology 164: 1361-1368.
5. Bindels, L.B., Delzenne, N.M., Cani, P.D. and Walter, J., 2015. Towards a more comprehensive concept for prebiotics. Nature Reviews Gastroenterology and Hepatology 12: 303-310.
6. Blijlevens, N.M., Donnelly, J.P. and De Pauw, B.E., 2000. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplantation 25: 1269-1278.
7. Carvalho, R.D., Breyner, N., Menezes-Garcia, Z., Rodrigues, N.M., Lemos, L., Maioli, T.U., Da Gloria Souza, D., Carmona, D., De Faria, A.M., Langella, P., Chatel, J.M., Bermudez-Humaran, L.G., Figueiredo, H.C., Azevedo, V. and De Azevedo, M.S., 2017. Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis. Microbial Cell Factories 16: 27.
8. Desai, M.S., Seekatz, A.M., Koropatkin, N.M., Kamada, N., Hickey, C.A., Wolter, M., Pudlo, N.A., Kitamoto, S., Terrapon, N., Muller, A., Young, V.B., Henrissat, B., Wilmes, P., Stappenbeck, T.S., Núñez, G. and Martens, E.C., 2016. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167: 1339-1353.
9. Elian, S.D., Souza, E.L., Vieira, A.T., Teixeira, M.M., Arantes, R.M., Nicoli, J.R. and Martins, F.S., 2015. Bifidobacterium longum subsp. infantis BB-02 attenuates acute murine experimental model of inflammatory bowel disease. Beneficial Microbes 6: 277-286.
10. Ferreira, T.M., Leonel, A.J., Melo, M.A., Santos, R.R., Cara, D.C., Cardoso, V.N., Correia, M.I. and Alvarez-Leite, J.I., 2012. Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-fluorouracil administration. Lipids 47: 669-678.
11. Fitzmaurice, C., et al., 2015. The global burden of cancer 2013. JAMA Oncology 1: 505-527.
12. Generoso, S.e.V., Rodrigues, N.M., Trindade, L.M., Paiva, N.C., Cardoso, V.N., Carneiro, C.M., Ferreira, A.V., Faria, A.M. and Maioli, T.U., 2015. Dietary supplementation with omega-3 fatty acid attenuates 5-fluorouracil induced mucositis in mice. Lipids in Health and Disease 14: 54.
13. Hamouda, N., Sano, T., Oikawa, Y., Ozaki, T., Shimakawa, M., Matsumoto, K., Amagase, K., Higuchi, K. and Kato, S., 2017. Apoptosis, dysbiosis and expression of inflammatory cytokines are sequential events in the development of 5-fluorouracil-induced intestinal mucositis in mice. Basic and Clinical Pharmacology and Toxicology 121: 159-168.
14. Keefe, D.M., 2007. Intestinal mucositis: mechanisms and management. Current Opinion in Oncology 19: 323-327.
15. Kolida, S. and Gibson, G.R., 2011. Synbiotics in health and disease. Annual Review of Food Science and Technology 2: 373-393.
16. Kumar, M., Kissoon-Singh, V., Coria, A.L., Moreau, F. and Chadee, K., 2017. Probiotic mixture VSL#3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice. American Journal of Physiology Gastrointestinal and Liver Physiology 312: G34-G45.
17. Lalla, R.V., Bowen, J., Barasch, A., Elting, L., Epstein, J., Keefe, D.M., McGuire, D.B., Migliorati, C., Nicolatou-Galitis, O., Peterson, D.E., Raber-Durlacher, J.E., Sonis, S.T., Elad, S. and Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO), 2014. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120: 1453-1461.
18. Leonel, A.J., Teixeira, L.G., Oliveira, R.P., Santiago, A.F., Batista, N.V., Ferreira, T.R., Santos, R.C., Cardoso, V.N., Cara, D.C., Faria, A.M. and Alvarez-Leite, J., 2013. Antioxidative and immunomodulatory effects of tributyrin supplementation on experimental colitis. British Journal of Nutrition 109: 1396-1407.
19. Li, J., Hou, N., Faried, A., Tsutsumi, S., Takeuchi, T. and Kuwano, H., 2009. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Annals of Surgical Oncology 16: 761-771.
20. Longley, D.B., Harkin, D.P. and Johnston, P.G., 2003. 5-fluorouracil: mechanisms of action and clinical strategies. Nature Reviews Cancer 3: 330-338.
21. Lugea, A., Salas, A., Casalot, J., Guarner, F. and Malagelada, J.R., 2000. Surface hydrophobicity of the rat colonic mucosa is a defensive barrier against macromolecules and toxins. Gut 46: 515-521.
22. Maioli, T.U., De Melo Silva, B., Dias, M.N., Paiva, N.C., Cardoso, V.N., Fernandes, S.O., Carneiro, C.M., Dos Santos Martins, F. and De Vasconcelos Generoso, S., 2014. Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice. Journal of Negative Results in Biomedicine 13: 6.
23. Morelli, L., Zonenschain, D., Callegari, M.L., Grossi, E., Maisano, F. and Fusillo, M., 2003. Assessment of a new synbiotic preparation in healthy volunteers: survival, persistence of probiotic strains and its effect on the indigenous flora. Nutrition Journal 2: 11.
24. Park, J., Kim, M., Kang, S.G., Jannasch, A.H., Cooper, B., Patterson, J. and Kim, C.H., 2015. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunology 8: 80-93.
25. Pedroso, S.H., Vieira, A.T., Bastos, R.W., Oliveira, J.S., Cartelle, C.T., Arantes, R.M., Soares, P.M., Generoso, S.V., Cardoso, V.N., Teixeira, M.M., Nicoli, J.R. and Martins, F.S., 2015. Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice. Microbiology 161: 1950-1960.
26. Peng, L., He, Z., Chen, W., Holzman, I.R. and Lin, J., 2007. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatric Research 61: 37-41.
27. Rastall, R.A., Gibson, G.R., Gill, H.S., Guarner, F., Klaenhammer, T.R., Pot, B., Reid, G., Rowland, I.R. and Sanders, M.E., 2005. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiology Ecology 52: 145-152.
28. Roberfroid, M.B., 1998. Prebiotics and synbiotics: concepts and nutritional properties. British Journal of Nutrition 80: S197-S202.
29. Sattler, V.A., Bayer, K., Schatzmayr, G., Haslberger, A.G. and Klose, V., 2015. Impact of a probiotic, inulin, or their combination on the piglets' microbiota at different intestinal locations. Beneficial Microbes 6: 473-483.
30. Smith, C.L., Geier, M.S., Yazbeck, R., Torres, D.M., Butler, R.N. and Howarth, G.S., 2008. Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats. Nutrition and Cancer 60: 757-767.
31. Soares, P.M., Mota, J.M., Gomes, A.S., Oliveira, R.B., Assreuy, A.M., Brito, G.A., Santos, A.A., Ribeiro, R.A. and Souza, M.H., 2008. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemotherapy and Pharmacology 63: 91-98.
32. Sonis, S.T., 1998. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncology 34: 39-43.
33. Souza, B.M., Preisser, T.M., Pereira, V.B., Zurita-Turk, M., De Castro, C.P., Da Cunha, V.P., De Oliveira, R.P., Gomes-Santos, A.C., De Faria, A.M., Machado, D.C., Chatel, J.M., Azevedo, V.A., Langella, P. and Miyoshi, A., 2016. Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells. Microbial Cell Factories 15: 150.
34. Spyropoulos, B.G., Theodoropoulos, G., Misiakos, E.P., Stoidis, C.N., Zapatis, H., Diamantopoulou, K., Gialeli, C., Karamanos, N.K., Karatzas, G., Machairas, A., Fotiadis, C., Zografos, G.C., Kelekis, N. and Kouloulias, V., 2013. The effect of synbiotics on acute radiation-induced diarrhea and its association with mucosal inflammatory and adaptive responses in rats. Digestive Diseases and Sciences 58: 2487-2498.
35. Tiago, F.C., Porto, B.A., Ribeiro, N.S., Moreira, L.M., Arantes, R.M., Vieira, A.T., Teixeira, M.M., Generoso, S.V., Nascimento, V.N., Martins, F.S. and Nicoli, J.R., 2015. Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel disease. Beneficial Microbes 6: 807-815.
36. Tooley, K.L., Howarth, G.S., Lymn, K.A., Lawrence, A. and Butler, R.N., 2011. Oral ingestion of Streptococcus thermophilus does not affect mucositis severity or tumor progression in the tumor-bearing rat. Cancer Biology and Therapy 12: 131-138.
37. Touchefeu, Y., Montassier, E., Nieman, K., Gastinne, T., Potel, G., Bruley des Varannes, S., Le Vacon, F. and De La Cochetière, M.F., 2014. Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications. Alimentary Pharmacology & Therapeutics 40: 409-421.
38. Van Vliet, M.J., Harmsen, H.J., De Bont, E.S. and Tissing, W.J., 2010. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathogens 6: e1000879.
39. Wang, H., Geier, M.S. and Howarth, G.S., 2016. Prebiotics: a potential treatment strategy for the chemotherapy-damaged gut? Critical Reviews in Food Science and Nutrition 56: 946-956.
40. Wasilewski, A., Zielinska, M., Storr, M. and Fichna, J., 2015. Beneficial effects of probiotics, prebiotics, synbiotics, and psychobiotics in inflammatory bowel disease. Inflammatory Bowel Diseases 21: 1674-1682.
41. Whitford, E.J., Cummins, A.G., Butler, R.N., Prisciandaro, L.D., Fauser, J.K., Yazbeck, R., Lawrence, A., Cheah, K.Y., Wright, T.H., Lymn, K.A. and Howarth, G.S., 2009. Effects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent, 5-Fluorouracil (5-FU). Cancer Biology and Therapy 8: 505-511.
42. Yuan, K.T., Yu, H.L., Feng, W.D., Chong, P., Yang, T., Xue, C.L., Yu, M. and Shi, H.P., 2015. Bifidobacterium infantis has a beneficial effect on 5-fluorouracil-induced intestinal mucositis in rats. Beneficial Microbes 6: 113-118.